Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Cantor Fitzgerald
Federal Trade Commission
Express Scripts
US Army
Fish and Richardson

Generated: June 28, 2017

DrugPatentWatch Database Preview

Levopropoxyphene napsylate anhydrous - Generic Drug Details

« Back to Dashboard

What are the generic sources for levopropoxyphene napsylate anhydrous and what is the scope of levopropoxyphene napsylate anhydrous freedom to operate?

Levopropoxyphene napsylate anhydrous
is the generic ingredient in one branded drug marketed by Lilly and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Summary for Generic Name: levopropoxyphene napsylate anhydrous

Bulk Api Vendors: see list12
Clinical Trials: see list19
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:levopropoxyphene napsylate anhydrous at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
levopropoxyphene napsylate anhydrous
SUSPENSION;ORAL012928-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
levopropoxyphene napsylate anhydrous
CAPSULE;ORAL012928-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
levopropoxyphene napsylate anhydrous
CAPSULE;ORAL012928-006Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Chinese Patent Office
Cantor Fitzgerald
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus